TABLE 4.
Representative different active materials coated on microneedle patches This is not an exhaustive list. The objective of this table is to provide an assortment of active materials that have been coated on microneedles, along with their respective ranges.
Active Material Coated | Coating Method | Total Amount Coated (Total Microneedle Shafts in the Patch That Are Coated)a/b |
---|---|---|
Viruses and bacteria | ||
Bacillus Calmette-Guérin vaccine | Dip | 0.83 μg (5 microneedles)a (Hiraishi et al., 2011) |
Francisella novicida | Immersion | 2.5 × 106 CFU/ml (77 microneedles)b (Chandler et al., 2018) |
Human papillomavirus: Gardasil | Drop–gas jet | 300ng–0.43 ng HPV vaccine (3364 microneedles)b (Corbett et al., 2010) |
Inactivated chikungunya virus | Drop–gas jet | 0.38 μg (3364 microneedles)b (Prow et al., 2010) |
Inactivated polio virus | Drop–gas jet | 1 D-antigen units (10,000 microneedles)b (Muller et al., 2016) |
Inactivated split influenza virus | Dip | 3 μg (5 microneedles)a (Koutsonanos et al., 2012) |
Inactivated split influenza virus | Dip | 30–45 μg (320 microneedles)a (Kommareddy et al., 2013) |
Inactivated split influenza virus | Drop–gas jet | 37 ng (3364 microneedles)b (McNeilly et al., 2014) |
Inactivated split influenza virus | Drop–gas jet | 15 μg hemagglutinin (10,000 microneedles)b (Fernando et al., 2018) |
Inactivated whole influenza virus | Dip | 0.4 μg (5 microneedles)a (Quan et al., 2009) |
Inactivated whole influenza virus | Dip | 3 or 10 μg (5 microneedles)a (Koutsonanos et al., 2009) |
Inactivated rotavirus vaccine | Dip | 5 or 0.5 μg (5 microneedles)a (Moon et al., 2013) |
Live measles vaccine virus | Dip | 200 or 1000 TCID50 (5 microneedles)a (Edens et al., 2013) |
Pneumococcal-conjugate vaccine | Drop–gas jet | 1 μg (21,400 microneedles)b (Pearson et al., 2015) |
Trivalent inactivated whole influenza viruses | Dip | 6 μg ((5 microneedles)a (Kim et al., 2016b) |
Virus-like particles (VLPs) | ||
Influenza VLPs | Dip | 0.4 μg (5 microneedles)a (Song et al., 2010) |
Influenza VLPs | Dip | 10 μg (5 microneedles)a (Pearton et al., 2013) |
Oligonucleotides | ||
DNA vaccine (hepatitis C virus, nonstructural 3/4 A protein) | Dip | 1.6 μg (5 microneedles)a (Gill et al., 2010) |
DNA vaccine (herpes simplex virus type 2 US6) | Drop–gas jet | 400–4 ng (3364 microneedles)b (Kask et al., 2010) |
DNA vaccine (influenza virus hemagglutinin) | Dip | 3.6 μg DNA (5 microneedles)a (Kim et al., 2012) |
DNA vaccine (influenza virus nucleoprotein) | Drop–gas jet | 10 μg (3364 microneedles)b (Fernando et al., 2016) |
DNA vaccine (Leishmania) | Dip | 20 μg DNA (10 microneedles)a (Moreno et al., 2017) |
Oligonucleotide | Dip | 0.136 nmol (5 microneedles)a (Luo et al., 2013) |
siRNA | Dip | 40 μg (10 microneedles)a (Chong et al., 2013) |
Peptides and proteins | ||
Bevacizumab (antibody) | Dip | 1.1 μg (5 microneedles)a (Kim et al., 2014) |
Bovine serum albumin (protein) | Dip | 30 μg (64 microneedles)a (Caudill et al., 2018) |
Bovine serum albumin (protein) | Dip | 20–100 μg (50 microneedles)a (Andrianov et al., 2009) |
Der p1 (house dust mite allergen protein) | Dip | 25 ± 25 μg CpG (57 microneedles)a (Shakya et al., 2018) |
Desmopressin (peptide) | Dip | 82 μg (642 microneedles)a (Cormier et al., 2004) |
Diphtheria toxoid (protein) | Layer-by-layer | 0.05–0.6 μg (576 microneedles)b (Schipper et al., 2017) |
Ebola virus glycoprotein | Dip | 0.63 μg (5 microneedles)a (Liu et al., 2018) |
Erythropoietin (protein) | Dip | 200 μg (1950 microneedles)a (Peters et al., 2012) |
Exendin-4 (peptide) | Dip | 0.5–4 μg (140 microneedles)a (Liu et al., 2016) |
M2e-flagellin (fusion protein) | Dip | 1.4 μg (5 microneedles)a (Wang et al., 2014) |
Ovalbumin (protein) | Dip | 25 ± 25 μg CpG (57 microneedles)a (Shakya et al., 2017) |
Ovalbumin (protein) | Drop–gas jet | 5 μg OVA (3364 microneedles)b (Ng et al., 2012) |
Parathyroid hormone peptide | Dip | 20, 30, 40 μg (1300 microneedles)a (Daddona et al., 2011) |
Peptides and CpG (oligonucleotide) | Layer-by-layer | 5 to 6 μg (77 microneedles)b (Zeng et al., 2017) |
Recombinant human growth hormone (protein) | Dip | 500 μg (1740 microneedles)a (Ameri et al., 2014) |
Salmon calcitonin (cyclic polypeptide) | Dip | 1.5 μg (5 microneedles)a (Tas et al., 2012) |
Small molecules | ||
5-Aminolevulinic acid | Dip | 206–680 μg (57 microneedles)a (Jain et al., 2016) |
Alendronate | Dip | 15 μg (190 microneedles)a (Katsumi et al., 2017) |
Bleomycin | Dip | 62–518 μg (100 microneedles)a (Lee et al., 2017a) |
Calcein | Dip | 0.13–21 μg (144 microneedles)a (Chen et al., 2015) |
Curcumin, 5-fluorouracil, sodium fluorescein | Inkjet | 24–118 μg (50 microneedles)a (Uddin et al., 2015) |
Doxorubicin encapsulated in particles | Dip | 0.6 μg (5 microneedles)a (Ma et al., 2015) |
Lidocaine | Dip | 45–94 μg (316 microneedles)a (Zhang et al., 2012b) |
Lidocaine | Dip | 290 μg (256 microneedles)a (Baek et al., 2017) |
Lidocaine | Dip (molten drug) | 15 μg (5 microneedles)a (Ma and Gill, 2014) |
Paclitaxel | Dip | 1 μg (9 microneedles)a (Lee et al., 2014) |
Sulforhodamine | Dip | 132–835 ng (25 microneedles)a (Chen et al., 2017) |
Sulforhodamine | Dip | 15 μg (57 microneedles)a (Serpe et al., 2016) |
Zolmitriptan | Dip | 1.9 mg (1987 microneedles)a (Spierings et al., 2018) |
3.8 mg (microneedle number unclear)a (Kellerman et al., 2017) |
Amount coated on microneedle shafts.
Amount delivered into skin (for coating methods that generate coatings on microneedle shaft and base of patch).